XML 32 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Estimated Fair Value of Stock Option Award

The estimated fair value of each stock option award granted was determined on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions for option grants during the six months ended June 30, 2014. No options were granted during the six months ended June 30, 2013.

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2014   2013      2014   2013  

Common Stock Options

         

Risk free interest rate

   1.66%     —         1.66 - 1.77%     —     

Expected option term

   5.5 years     —         5.5 - 6.0 years     —     

Expected volatility of common stock

   71.06%     —         71.06 - 73.21%     —     

Expected dividend yield

   0.0%     —         0.0%     —     
Summary of Estimated Fair Value of Employee Stock Purchase Plan Award

The estimated fair value of each employee stock purchase plan award was determined on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions for options grants during the six months ended June 30, 2014. The employee stock purchase plan did not become active until March 2014.

 

     Three and Six Months Ended
June 30,
 
     2014    2013  

Employee Stock Purchase Plan

     

Risk free interest rate

   0.08%      —     

Expected option term

   6.0 months      —     

Expected volatility of common stock

   73.21%      —     

Expected dividend yield

   0.0%      —     
Summary of Non-Cash Share-Based Compensation Expense

The Company recognized non-cash stock-based compensation expense to employees and directors in its research and development and its general and administrative functions as follows:

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2014      2013      2014      2013  

Research and development

   $ 104,759       $ 1,563       $ 197,424       $ 4,064   

General and administrative

     160,451         1,563         291,096         2,188   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 265,210       $ 3,126       $ 488,520       $ 6,252